[go: up one dir, main page]

CA2014889A1 - Composes pharmaceutiques - Google Patents

Composes pharmaceutiques

Info

Publication number
CA2014889A1
CA2014889A1 CA2014889A CA2014889A CA2014889A1 CA 2014889 A1 CA2014889 A1 CA 2014889A1 CA 2014889 A CA2014889 A CA 2014889A CA 2014889 A CA2014889 A CA 2014889A CA 2014889 A1 CA2014889 A1 CA 2014889A1
Authority
CA
Canada
Prior art keywords
intra
foam compositions
pharmaceutical foam
rectal pharmaceutical
foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2014889A
Other languages
English (en)
Other versions
CA2014889C (fr
Inventor
John Norman Charles Healey
Marshall Whiteman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals SARL
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10655759&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2014889(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of CA2014889A1 publication Critical patent/CA2014889A1/fr
Application granted granted Critical
Publication of CA2014889C publication Critical patent/CA2014889C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002014889A 1989-04-26 1990-04-19 Composes pharmaceutiques Expired - Lifetime CA2014889C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898909559A GB8909559D0 (en) 1989-04-26 1989-04-26 Pharmaceutical compositions
GB8909559.0 1989-04-26

Publications (2)

Publication Number Publication Date
CA2014889A1 true CA2014889A1 (fr) 1990-10-26
CA2014889C CA2014889C (fr) 2000-05-30

Family

ID=10655759

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002014889A Expired - Lifetime CA2014889C (fr) 1989-04-26 1990-04-19 Composes pharmaceutiques

Country Status (17)

Country Link
US (1) US5082651A (fr)
EP (1) EP0395329B2 (fr)
JP (1) JP2566662B2 (fr)
KR (1) KR0179344B1 (fr)
AT (1) ATE124261T1 (fr)
AU (1) AU623245B2 (fr)
CA (1) CA2014889C (fr)
DE (1) DE69020422T3 (fr)
DK (1) DK0395329T4 (fr)
ES (1) ES2074124T5 (fr)
GB (1) GB8909559D0 (fr)
GR (2) GR3017367T3 (fr)
HK (1) HK1004521A1 (fr)
IE (1) IE67621B1 (fr)
NZ (1) NZ233415A (fr)
PT (1) PT93884B (fr)
ZA (1) ZA903127B (fr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000485D0 (sv) * 1990-02-09 1990-02-09 Pharmacia Ab Foamable composition for pharmaceutical use, use thereof and method of treatment
IT1243379B (it) * 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
DE69133348T3 (de) * 1990-10-22 2011-05-12 Centre for Digestive Diseases Pty, Ltd. Behandlung von nicht-entzündlichen darmerkrankungen
IT1247529B (it) * 1991-04-24 1994-12-17 Poli Ind Chimica Spa Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale
CZ280758B6 (cs) * 1991-06-07 1996-04-17 Byk Nederland B.V. Vodná suspenze kyseliny 5-aminosalicylové pro podávání ve formě klysmatu
FR2713486B1 (fr) * 1993-12-14 1996-02-09 Scophysa Nouvelles compositions pour mousses, notamment mousses rectales, et mousses ainsi obtenues.
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
GB9503119D0 (en) * 1995-02-17 1995-04-05 Durand Ltd Medication and apparatus and method of applying medication
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
JP2001072576A (ja) * 1999-09-03 2001-03-21 Kissei Pharmaceut Co Ltd 経口用医薬品組成物
AU780838B2 (en) * 1999-09-06 2005-04-21 Kaori Ueda Chemical peeling agent
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
CA2495537C (fr) * 2000-08-29 2010-03-30 Nobex Corporation Composes et derives immunomodulateurs et methodes de traitement des maladies
CA2359812C (fr) * 2000-11-20 2004-02-10 The Procter & Gamble Company Formes posologiques pharmaceutiques a couches multiples permettant de reduire l'impact des revetement fractures
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
EP1312368A1 (fr) * 2001-11-19 2003-05-21 Dr. Falk Pharma Gmbh Composition comprenant de la mesalazine pour le traitement des maladies intestinales inflammatoires
IL152486A0 (en) * 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20070292359A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
US20080206161A1 (en) * 2002-10-25 2008-08-28 Dov Tamarkin Quiescent foamable compositions, steroids, kits and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
CA2502986C (fr) * 2002-10-25 2011-08-23 Foamix Ltd. Mousse cosmetique et pharmaceutique
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7700076B2 (en) * 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7575739B2 (en) * 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
AU2004261063A1 (en) * 2003-08-04 2005-02-10 Foamix Ltd. Foam carrier containing amphiphilic copolymeric gelling agent
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP2422768B1 (fr) * 2003-08-25 2015-04-15 Foamix Pharmaceuticals Ltd. Mousse pharmaceutique pénétrante
US8916546B2 (en) 2003-08-29 2014-12-23 Therapeutic Research Llc Materials and methods for treatment and diagnosis of disorders associated with oxidative stress
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
WO2005076697A2 (fr) * 2004-02-04 2005-08-25 Foamix Ltd. Mousse cosmetique et pharmaceutique comprenant des matieres solides
ES2565848T3 (es) 2004-07-07 2016-04-07 Biocon Limited Síntesis de compuestos inmunorreguladores unidos por grupos azoicos
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
EA200970260A1 (ru) * 2006-09-08 2009-08-28 Фоамикс Лтд. Окрашенная или окрашиваемая и вспениваемая композиция и пена
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
AU2007356328A1 (en) * 2006-11-14 2009-01-15 Tal Berman Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
EP2392321A1 (fr) * 2007-06-13 2011-12-07 Jay Pravda Composition combinée pour l'administration rectale pour le traitment des maladies intestinales inflammatoires
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (fr) 2007-12-07 2009-06-11 Foamix Ltd. Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
EP2242476A2 (fr) * 2008-01-14 2010-10-27 Foamix Ltd. Compositions pharmaceutiques pouvant mousser de poloxamère avec des agents actifs et/ou des cellules thérapeutiques, et utilisations
WO2010125470A2 (fr) 2009-04-28 2010-11-04 Foamix Ltd. Véhicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
CA2769677A1 (fr) 2009-07-29 2011-02-03 Foamix Ltd. Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
CA2769625C (fr) 2009-07-29 2017-04-11 Foamix Ltd. Compositions hydro-alcooliques moussantes non tensioactives, mousses legeres, et leurs utilisations
CA2776471C (fr) 2009-10-02 2019-02-12 Foamix Ltd. Compositions moussantes depourvues d'agent tensioactif et d'eau et mousses cassables et leurs utilisations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
NZ600358A (en) 2009-11-23 2014-05-30 Cipla Ltd Topical foam composition
RU2012126084A (ru) 2009-11-23 2013-12-27 Сипла Лимитед Пенная композиция для местного применения
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
CA2891090A1 (fr) 2012-11-09 2014-05-15 Scidose, Llc Composition de lavement pour le traitement de la colite ulcereuse ayant une stabilite a long terme
JP2015168654A (ja) * 2014-03-07 2015-09-28 三笠製薬株式会社 ＮＳＡＩＤｓ含有泡沫化製剤用水性組成物
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.
EP3554473A1 (fr) * 2016-12-16 2019-10-23 Ferring B.V. Formulations de mousse rectale

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1304682A (fr) * 1969-02-03 1973-01-24
US3866800A (en) * 1969-02-12 1975-02-18 Alberto Culver Co Non-pressurized package containing self-heating products
AU1314370A (en) * 1970-02-09 1971-09-30 Alberto-Culver Company Gas-releasable and foamable compositions
US3997467A (en) * 1971-11-26 1976-12-14 Pharmacia Aktiebolag Foam forming composition
AR205589A1 (es) * 1974-10-09 1976-05-14 Reckitt & Colmann Prod Ltd Dispositivo introductor de una composicion acuosa en una cavidad corporal
US4112942A (en) * 1974-10-09 1978-09-12 Reckitt & Colman Products Limited Method of preparing and administering a foam enema
DE2755224A1 (de) * 1976-12-15 1978-07-13 Procter & Gamble Schmerzen und entzuendungen linderndes mittel zur oertlichen anwendung
US4211777A (en) * 1977-11-25 1980-07-08 Fisons Limited Compositions comprising a compound having sodium cromoglycate activity and aminosalicylic acid
WO1981002672A1 (fr) * 1980-03-20 1981-10-01 Ferring Farma Lab Composition pharmaceutique et procede de traitement de la colite ulcereuse et de la maladie de crohn
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
SU1172558A1 (ru) * 1983-07-11 1985-08-15 Научно-исследовательский институт проктологии Способ лечени воспалительных заболеваний толстой кишки
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4657900A (en) * 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
FR2561919B1 (fr) * 1984-04-03 1986-12-19 Roussel Uclaf Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon
US4639367A (en) * 1985-03-18 1987-01-27 Product Resources International, Inc. Aerosol foam
US4752465A (en) * 1985-09-20 1988-06-21 Product Resources International, Inc. Aerosol foam
US4889709A (en) * 1985-03-18 1989-12-26 Product Resources International, Inc. Aerosol foam with adsorbate and container containing same
EP0251462A3 (fr) * 1986-05-28 1988-10-26 Lloyd I. Osipow Compositions contenant un polymère et un agent propulsant pour préparer des structures moussées
US4933330A (en) * 1987-04-01 1990-06-12 Dak-Laboratoriet Benzoic acid derivatives and use thereof
US4945084A (en) * 1987-07-08 1990-07-31 Norman Oksman Method and composition for topically treating anorectal or other dermal wounds

Also Published As

Publication number Publication date
GB8909559D0 (en) 1989-06-14
JPH02295928A (ja) 1990-12-06
IE901469L (en) 1990-10-26
DE69020422D1 (de) 1995-08-03
KR0179344B1 (ko) 1999-03-20
PT93884B (pt) 1996-10-31
DK0395329T3 (da) 1995-10-30
ZA903127B (en) 1991-12-24
EP0395329A3 (fr) 1991-11-21
ATE124261T1 (de) 1995-07-15
US5082651A (en) 1992-01-21
ES2074124T5 (es) 2000-01-16
EP0395329B2 (fr) 1999-11-17
HK1004521A1 (en) 1998-11-27
IE67621B1 (en) 1996-04-17
DE69020422T3 (de) 2000-03-30
DE69020422T2 (de) 1995-11-16
CA2014889C (fr) 2000-05-30
AU623245B2 (en) 1992-05-07
DK0395329T4 (da) 2000-04-10
JP2566662B2 (ja) 1996-12-25
AU5367290A (en) 1990-11-01
GR3017367T3 (en) 1995-12-31
GR3032575T3 (en) 2000-05-31
EP0395329B1 (fr) 1995-06-28
NZ233415A (en) 1991-05-28
ES2074124T3 (es) 1995-09-01
EP0395329A2 (fr) 1990-10-31
PT93884A (pt) 1990-11-20
KR900015741A (ko) 1990-11-10

Similar Documents

Publication Publication Date Title
CA2014889A1 (fr) Composes pharmaceutiques
HUT55220A (en) Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
CA2125662A1 (fr) Systeme a administration transdermique contenant de l'acide acetylsalicylique pour le traitement de la thrombose et la prophylaxie du cancer
EP0348808A3 (fr) Formulations pharmaceutiques et procédé pour leur préparation
YU48583B (sh) Postupak za pripremanje formulacije u obliku pilule za oralno davanje
CA2004598A1 (fr) Aerosols medicinaux
MY101593A (en) Sustained release preparation.
LU90297I2 (fr) Rivastigmine ses sels et dérivés pharmaceutiquement acceptables en particulier la rivastigmine sous forme d'hydrogénotartrate
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
HUT48623A (en) Herbicides comprising 2,5-dihydropyrrole derivatives as active ingredient and process for producing 2,5-dihydropyrrole derivatives
HUT47233A (en) Process for producing pharmaceutical comprising phenol derivatives as active ingredient and for producing the active ingredients
NZ230356A (en) 2',3'-dideoxy-5-ethynyl-3'-fluorouridine: preparatory processes and pharmaceutical compositions
EP0362847A3 (fr) Emploi de l'étopéritone pour obtenir une composition pharmaceutique pour le traitement de l'impotence chez l'homme
NO931011L (no) 7-okso-7h-pyrido(1,2,3-de)(1,4)benzoksacin-6-karbonsyrer og -estere
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
CA2101548A1 (fr) Acides acylamino-alylidenehydroxy-bisphosphoniques, utiles pour le traitement des maladies osteoarticulaires
HUT49054A (en) Process for producing pharmaceutical compositions absorbed through the derm and comprising pyrazolo(1,5-a) pyridine derivatives as active ingredient
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use
IT1255380B (it) Nitrobenzoilalanine,procedimento per la loro preparazione,loro uso come agenti terapeutici e composizioni farmaceutiche che le contengono
HU913832D0 (en) Process for the production of medical preparations in capsules, containing alcali-hydrogen-carbonates as active agents
HU904983D0 (en) Process for producing imidazo(5,1-b)quinazoline-9-one derivatives and their pharmaceutically acceptible salts as well as process for producing pharmaceutical preparatives containing these active substances

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry